artificial liver - subjective presentation
TRANSCRIPT
04/11/2304/11/23 11
Artificial LiverArtificial Liver
Nandini DhimanNandini Dhiman
M.Tech - BMEM.Tech - BME
04/11/2304/11/23 22
Biology of the LiverBiology of the Liver
Left lobeRight lobe
KidneysGallbladder
Inferior Vena Cava
04/11/2304/11/23 33
LiverLiver
It is both the largest It is both the largest internalinternal organ (the organ (the skin being the largest organ overall) and skin being the largest organ overall) and the largest gland in the human bodythe largest gland in the human body
The various functions of the liver are The various functions of the liver are carried out by the liver cells or carried out by the liver cells or hepatocyteshepatocytes
04/11/2304/11/23 44
What does the Liver do?What does the Liver do?
Among the most important liver functions are:Among the most important liver functions are: Removing and excreting body wastes and hormones as Removing and excreting body wastes and hormones as
well as drugs and other foreign substanceswell as drugs and other foreign substances Synthesizing plasma proteins, including those necessary Synthesizing plasma proteins, including those necessary
for blood clotting for blood clotting Producing immune factors and removing bacteria, Producing immune factors and removing bacteria,
helping the body fight infection helping the body fight infection
Other important but less immediate functions include:Other important but less immediate functions include: Producing bile to aid in digestion Producing bile to aid in digestion Excretion of bilirubin Excretion of bilirubin Storing certain vitamins, minerals, and sugars Storing certain vitamins, minerals, and sugars Processing nutrients absorbed from digestive tractProcessing nutrients absorbed from digestive tract
04/11/2304/11/23 55
RegenerationRegeneration
The liver is the only internal human organ The liver is the only internal human organ capable of natural regeneration of lost capable of natural regeneration of lost tissue tissue
As little as 25% of a liver can regenerate As little as 25% of a liver can regenerate into a whole liver into a whole liver
This is predominantly due to the This is predominantly due to the hepatocytes re-entering the cell cycle hepatocytes re-entering the cell cycle
04/11/2304/11/23 66
Bioartificial LiverBioartificial Liver
A A bioartificial liver device (BAL)bioartificial liver device (BAL) is an artificial is an artificial extracorporeal supportive device for an individual with liver extracorporeal supportive device for an individual with liver failure, acute or chronicfailure, acute or chronic
Such devices are in principle more complex than dialysis and Such devices are in principle more complex than dialysis and filtration systems, they could provide biochemical and filtration systems, they could provide biochemical and synthetic functions that are not available in the systems synthetic functions that are not available in the systems containing no cells containing no cells
““Tissue Engineering and Artificial Organs - Joseph D. Bronzino”Tissue Engineering and Artificial Organs - Joseph D. Bronzino”
04/11/2304/11/23 77
Why would someone need a Bioartificial Why would someone need a Bioartificial Liver?Liver?
Liver diseasesLiver diseases Infections such as hepatitis A, B, C, E,Infections such as hepatitis A, B, C, E, Alcohol damageAlcohol damage Fatty liver Fatty liver Cirrhosis Cirrhosis CancerCancer Drug damage (especially acetaminophen, cancer Drug damage (especially acetaminophen, cancer
drugs)drugs)
JaundiceJaundice Alpha-1 antitrypsin deficiencyAlpha-1 antitrypsin deficiency
04/11/2304/11/23 88
The path to liver disease and The path to liver disease and failurefailure
04/11/2304/11/23 99Healthy LiverHealthy Liver
04/11/2304/11/23 1010
A liver with cirrhosisA liver with cirrhosis
04/11/2304/11/23 1111
Liver Transplantation NowLiver Transplantation Now
Patients are in waiting list ranked according to severity of disease and life expectancy among other variables
Can be from a cadaveric donor or from a live donor Involves heavy use of immunosuppressants during and after
surgery The risk of rejection is always present
Liver Transplant Statistics in 2000
02000400060008000
100001200014000160001800020000
Transplants Waiting List
Pa
tie
nts
04/11/2304/11/23 1212
Requirements for a liver assist Requirements for a liver assist device/bioartificial liver:device/bioartificial liver:
1)1) Cellular components must be purified and every Cellular components must be purified and every component in it must be clearly identifiedcomponent in it must be clearly identified
2)2) The cellular preparation must be clearly shown to not The cellular preparation must be clearly shown to not transmit any infectious diseases of any kindtransmit any infectious diseases of any kind
3)3) The cellular component must stay viable and activeThe cellular component must stay viable and active
4)4) The synthetic component must be fully biocompatible, The synthetic component must be fully biocompatible, integrity of the material and parts must also be integrity of the material and parts must also be demonstrateddemonstrated
5)5) The device must be able to introduce the therapeutic The device must be able to introduce the therapeutic and regulatory molecules that a healthy liver provides, and regulatory molecules that a healthy liver provides, and it must also filter substances from the blood the and it must also filter substances from the blood the way that the normal liver doesway that the normal liver does
6)6) Must be immunocompatibleMust be immunocompatible7)7) Blood must perfuse properly through systemBlood must perfuse properly through system
04/11/2304/11/23 1313
Enabling Technologies for Bioartificial
Liver Development:
Hemodialysis/hemofiltration hollow fibresHemodialysis/hemofiltration hollow fibres - - Necessary for the controlled interaction of cells and Necessary for the controlled interaction of cells and circulating fluids. Biomaterials technology is also key circulating fluids. Biomaterials technology is also key to this area to this area
Maintenance of Cell line (hepatocyte cell Maintenance of Cell line (hepatocyte cell line) -line) - Cells used for liver therapy must be able to Cells used for liver therapy must be able to survive and/or proliferate in the device, and they must survive and/or proliferate in the device, and they must
also maintain their specific liver function.also maintain their specific liver function.
04/11/2304/11/23 1414
Cell SeparationCell Separation
Hepatocytes are separated from the liver Hepatocytes are separated from the liver by collagenase digestion, which is a two step by collagenase digestion, which is a two step process:process:
1.1. The liver is placed in an isotonic solution, in which calcium The liver is placed in an isotonic solution, in which calcium is removed to disrupt cell-cell tight junctions by the use of is removed to disrupt cell-cell tight junctions by the use of a calcium chelating agenta calcium chelating agent
2.2. A solution containing collagenase is added to separate the A solution containing collagenase is added to separate the hepatocytes from the liver parenchymahepatocytes from the liver parenchyma
This process creates a suspension of This process creates a suspension of hepatocytes, which can be culturedhepatocytes, which can be cultured
04/11/2304/11/23 1515
Extracorporeal Device DesignsExtracorporeal Device Designs
The components of extracorporeal The components of extracorporeal devices are:devices are:
- - the cellular component, the cellular component,
- membrane component, and - membrane component, and
- configuration- configuration
04/11/2304/11/23 1616
Different Types of Cellular Components present in Different Types of Cellular Components present in Bioartificial Livers (BAL) Bioartificial Livers (BAL)
Cellular Components of Bioartificial Liver
Concept Pros Cons
Primary Hepatocytes Cells isolated directly from the liver exhibit specific functions
If porcine: - proteins produced may cause immunogenic response
-concern with infection, animal handling, and hepatocytes harvest, isolation, and storage procedure
Immortalized Cell Lines Immortalized hepatocytes lines that are obtained from cultures:
- transforming human hepatocytes
-genetically engineered to proliferate
-cells allow for longer device operating time than primary hepatocytes
-if cultured from humans, it produces human proteins and cells are readily available
-Cells often lose function in vivo
-unclear whether fully differentiated hepatic and metabolic function is maintained
-outperformed by primary hepatocytes
-concern of spontaneous mutations or changes in gene expression during culture
-some cell lines are hepatoblastoma cell lines (tumor derived), which pose a theoretical threat of patient seeding
04/11/2304/11/23 1717
Hepatocytes must be anchoredHepatocytes must be anchored to a substrate in order to to a substrate in order to function properly. function properly.
Table : Anchoring Methods for Cells
Method Description Comments
MicrocarriersPolymeric particles containing cells. Alginate microspheres can be used.
Can be combined with ECM material to improve anchorage
Encapsulation
Envelopment of hepatocytes in a polymeric matrix. Can use polysaccharide hydrogels, collagen, or other materials.
Can be helpful in maintaining a three-dimensional structure for the hepatocytes
Hollow fibers
Luminal membranes that provide anchorage for hepatocytes. May be supplemented by ECM material (i.e. collagen)
May be coiled, bundled or wound to allow maximum length and surface area
04/11/2304/11/23 1818
Cell adhesion, growth, and function can be Cell adhesion, growth, and function can be greatly affected by the type of membrane greatly affected by the type of membrane used: it’s morphology, membrane used: it’s morphology, membrane hydrophilicity, and molecular-weight cutoff hydrophilicity, and molecular-weight cutoff (MWCO). (MWCO).
Membrane area, pore size, and thickness can Membrane area, pore size, and thickness can also affect biocompatibility and bioadhesionalso affect biocompatibility and bioadhesion
04/11/2304/11/23 1919
Table : Membranes used in Bioartificial Liver Devices
Membrane Charge MWCO (Kda) Comments
Cellulose acetate Positive 70-100 - Weak cell attachment- Sufficient metabolic activity- Low cell damage
Cuprophan Neutral <12 - Low thrombogenicity- No considerable cell attachment- High percentage of damaged cells
Hemophan Positive <10 - Adequate cell adhesion- Sufficient metabolic activity
Polyamide Not Applicable <1000 - Adequate cell adhesion- Satisfactory biocompatibility
Polypropylene -- <1000 - Adequate cell adhesion
Polysulfone Negative 100 - Increased cell attachment- Low cell damage- Maintenance of metabolic activity
04/11/2304/11/23 2020
Encapsulation TechnologyEncapsulation Technology
To eliminate the risk of rejection or the need to use To eliminate the risk of rejection or the need to use problematic antirejection drugs is to encapsulate “naked” problematic antirejection drugs is to encapsulate “naked” cells in polymeric substancescells in polymeric substances
PRINCIPLE: PRINCIPLE: - - To develop a capsule with sufficient permeability that To develop a capsule with sufficient permeability that
nutrients and oxygen can reach the transplanted cells, and nutrients and oxygen can reach the transplanted cells, and appropriate cellular products (insulin in the case of islet cells, for appropriate cellular products (insulin in the case of islet cells, for example) can be released into the bloodstream or to adjacent example) can be released into the bloodstream or to adjacent tissues tissues
- The capsular material must be restrictive enough to - The capsular material must be restrictive enough to exclude immune cells and antibodies that would cause rejection and exclude immune cells and antibodies that would cause rejection and destroy the implantdestroy the implant
04/11/2304/11/23 2121
PrinciplePrinciple
04/11/2304/11/23 2222
Several Polymeric Encapsulation Several Polymeric Encapsulation Systems Include:Systems Include:
Polysaccharide hydrogelsPolysaccharide hydrogels ChitosanChitosan Calcium or barium alginateCalcium or barium alginate A layered matrix of alginate and polylysineA layered matrix of alginate and polylysine
“ “Novocell, Inc., has developed a photopolymerizable Novocell, Inc., has developed a photopolymerizable poly(ethylene glycol) (PEG) polymer to encapsulate poly(ethylene glycol) (PEG) polymer to encapsulate individual cells or cell clusters. Various polyacrylates are individual cells or cell clusters. Various polyacrylates are also being tested, including polymers such as also being tested, including polymers such as hydroxyethyl methacrylate methyl methacrylate.”hydroxyethyl methacrylate methyl methacrylate.”
04/11/2304/11/23 2323
Cell sources
Human liver resections, at least 20% of the liver Human liver resections, at least 20% of the liver mass may be required for adequate liver support mass may be required for adequate liver support
Immortalized human cell line HepZImmortalized human cell line HepZ Hepatoblastoma cell lines HepG2 – Hepatoblastoma cell lines HepG2 – Problem is the Problem is the
possible risk in the transmission of potentially possible risk in the transmission of potentially tumorigenic cells to patientstumorigenic cells to patients
Xenogeneic hepatocytes – Xenogeneic hepatocytes – Problems are PERV, Problems are PERV, PCMV,PLHVPCMV,PLHV
Its Its notnot possible for self cell lines as they may be infected and possible for self cell lines as they may be infected and also time consumingalso time consuming
04/11/2304/11/23 2424
Maintenance of liver- specific functionsMaintenance of liver- specific functions
Complex extracellular matrix to maintain long-Complex extracellular matrix to maintain long-term differentiated hepatocytes in vitro thus a term differentiated hepatocytes in vitro thus a great interest in effective 3D culture systemsgreat interest in effective 3D culture systems
In contrast to a single layer of hydrated rat tail tendon collagen gel, In contrast to a single layer of hydrated rat tail tendon collagen gel, the sandwiching of rat hepatocytes between two collagen gel the sandwiching of rat hepatocytes between two collagen gel layers preserves a variety of liver-specific functions (Dunn et al. layers preserves a variety of liver-specific functions (Dunn et al. 1991, 1992)1991, 1992)
ECM remodeling in response to ECM remodeling in response to cytokinescytokines induces cell proliferation, an important induces cell proliferation, an important parameter of liver regenerationparameter of liver regeneration
Proliferation of hepatocytes is initiated by cytokine mediated Proliferation of hepatocytes is initiated by cytokine mediated G0/G1-transition of the cells, while the G1/S transition is also G0/G1-transition of the cells, while the G1/S transition is also controlled by hormones (Costa et al. 2003; Taub 2004)controlled by hormones (Costa et al. 2003; Taub 2004)
04/11/2304/11/23 2525
04/11/2304/11/23 2626
MethodsMethods
HCs and nonparenchymal liver cells from Lewis rats were seeded onto 3D biodegradable polymer scaffolds
Microporous 3D polymers were created using 3D printing on copolymers of polylactide-coglycolide (PLGA)
The cell/polymer constructs were placed in static culture or continuous flow conditions
The devices were retrieved after 2 days and examined by scanning electron microscopy and histology. Culture medium was analyzed for albumin by enzyme-linked immunosorbent assay (ELISA)
04/11/2304/11/23 2727
ResultsResults Scanning electron microscopy revealed
successful attachment of HCs on the 3D poymer in both static and flow conditions.
Histology demonstrated viable HCs in both conditions.
ELISA demonstrated a significantly higher mean concentration of albumin in flow conditions than in static conditions.
Culture parameter analysis revealed a significantly higher P02 and glucose level, and a more physiologic pH in flow conditions than in static conditions.
04/11/2304/11/23 2828
ConclusionConclusion
HCs cocultured with nonparenchymal cells can attach to and survive on the 3D polymer scaffolds in both static and flow conditions in the size and configuration used in this study.
Flow conditions may provide a more conducive environment for HC metabolism and albumin synthesis than static conditions
04/11/2304/11/23 2929
Bioreactor DesignsBioreactor Designs
A bioreactor refers to a device or A bioreactor refers to a device or system that supports a biologically system that supports a biologically active environment.active environment.
04/11/2304/11/23 3030
Hollow-FiberHollow-Fiber
04/11/2304/11/23 3131
04/11/2304/11/23 3232
04/11/2304/11/23 3333
Flat membrane systemsFlat membrane systems
Hepatocytes are co-cultured with non-Hepatocytes are co-cultured with non-parenchymal hepatic cells within an extracellular parenchymal hepatic cells within an extracellular matrix between oxygen permeable flat sheet matrix between oxygen permeable flat sheet polymeric membranes as individual platespolymeric membranes as individual plates
Micro porous PTFE membrane separate the cell Micro porous PTFE membrane separate the cell compartment from the medium compartment. compartment from the medium compartment. Protects against shear and regulates transferProtects against shear and regulates transfer
04/11/2304/11/23 3434
04/11/2304/11/23 3535
Comparison to liver dialysisComparison to liver dialysis
The advantages of using a BAL, over The advantages of using a BAL, over other dialysis-type devices (e.g. liver other dialysis-type devices (e.g. liver dialysis), is that metabolic functions (such dialysis), is that metabolic functions (such as lipid and plasma lipoprotein synthesis, as lipid and plasma lipoprotein synthesis, regulation of carbohydrate homeostasis, regulation of carbohydrate homeostasis, production of serum albumin and clotting production of serum albumin and clotting factors, etc.), in addition to detoxification, factors, etc.), in addition to detoxification, can be replicated without the use of can be replicated without the use of multiple devices multiple devices
04/11/2304/11/23 3636
Current Work on the Bioartificial Current Work on the Bioartificial LiverLiver
Molecular Adsorbent Recycling System Molecular Adsorbent Recycling System (MARS)(MARS)
Extracorporeal Liver Assist Device (ELAD)Extracorporeal Liver Assist Device (ELAD) HepatAssist 2000 SystemHepatAssist 2000 SystemExcorp Medical, Inc.'s Bioartificial Liver Excorp Medical, Inc.'s Bioartificial Liver
Support System (BLSS)Support System (BLSS) Algenix Inc.'s LIVERX2000 SystemAlgenix Inc.'s LIVERX2000 SystemModular Extracorporeal Liver System Modular Extracorporeal Liver System
(MELS) (MELS)
04/11/2304/11/23 3737
HepaLifeHepaLife
04/11/2304/11/23 3838
04/11/2304/11/23 3939
04/11/2304/11/23 4040
04/11/2304/11/23 4141
04/11/2304/11/23 4242
04/11/2304/11/23 4343
04/11/2304/11/23 4444
Current and Future ChallengesCurrent and Future Challenges
GOAL: To produce a fully implantable GOAL: To produce a fully implantable bioartificial liver.bioartificial liver.
Cell viability Fibrosis around implanted
capsules Proteins greater than pore
size cannot be released To achieve density of cells
needed to replace liver, an estimated 1000m of hollow fibers would be needed
Problems:
04/11/2304/11/23 4545
ReferencesReferences
http://www.hepalife.com/animation.phphttp://www.hepalife.com/animation.phphttp://biomed.brown.edu/Courses/BI108/http://biomed.brown.edu/Courses/BI108/
BI108_2002_Groups/liver/webpage/BI108_2002_Groups/liver/webpage/LDU_pg.htmLDU_pg.htm
http://en.wikipedia.org/wiki/http://en.wikipedia.org/wiki/Bioartificial_liver_deviceBioartificial_liver_device
http://en.wikipedia.org/wiki/Liverhttp://en.wikipedia.org/wiki/Liver
04/11/2304/11/23 4646
Thank YouThank You